Reported Late Tuesday, Burning Rock Biotech Q3 EPS $(0.31) Beats $(0.32) Estimate, Sales $21.74M Beat $21.15M Estimate
Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.32) by 3.13 percent. This is a 24 percent decrease over losses of $(0.25) per share from